NET PROFIT (x1000 EUR)
EMPLOYEES
Abigo Pharma A/S
Closing information (x1000 EUR)
| Closing information | 2021/12 | 2020/12 | 2019/12 |
| Turnover |
0
|
0
|
0 |
| Earnings before taxes |
799
|
28
|
-23 |
| Total assets |
1,070
|
914
|
864 |
| Current assets |
1,053
|
895
|
843 |
| Current liabilities |
463
|
660
|
680 |
| Equity capital |
601
|
-21
|
-42 |
| - share capital |
67
|
67
|
67 |
| Employees (average) |
7
|
7
|
7 |
Financial ratios
| Fiscal year | 2021/12 | 2020/12 | 2019/12 |
| Solvency |
56.2%
|
-2.3%
|
-4.9% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) | |||
| Current ratio |
227.4%
|
135.6%
|
124.0% |
| Return on equity (ROE) |
132.9%
|
-133.3%
|
54.8% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2021/12 | 2020/12 | 2019/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.